BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16384842)

  • 21. Menopause and the characteristics of the large arteries in a population study.
    Staessen JA; van der Heijden-Spek JJ; Safar ME; Den Hond E; Gasowski J; Fagard RH; Wang JG; Boudier HA; Van Bortel LM
    J Hum Hypertens; 2001 Aug; 15(8):511-8. PubMed ID: 11494087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women.
    Sweeney AT; Tangpricha V; Weinberg J; Malabanan AO; Chimeh FN; Holick MF
    Transl Res; 2006 Oct; 148(4):164-70. PubMed ID: 17002918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased 2-hydroxylation of estrogen is associated with lower body fat and increased lean body mass in postmenopausal women.
    Napoli N; Vattikuti S; Yarramaneni J; Giri TK; Nekkalapu S; Qualls C; Armamento-Villareal RC
    Maturitas; 2012 May; 72(1):66-71. PubMed ID: 22385932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of 17β-estradiol plus drospirenone on anthropometric and biochemical measures of adiposity in menopausal women.
    Karakus M; Gelisgen R; Topcuoglu A; Guralp O; Topcuoglu D; Simsek G; Uludag S; Uzun H
    Arch Gynecol Obstet; 2012 Nov; 286(5):1233-9. PubMed ID: 22791413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long-term effects of low-dose 17beta-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1-year randomized, prospective study.
    Kaya C; Dinçer Cengiz S; Cengiz B; Akgün G
    Climacteric; 2006 Dec; 9(6):437-45. PubMed ID: 17085376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study.
    Straub RH; Hense HW; Andus T; Schölmerich J; Riegger GA; Schunkert H
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1340-4. PubMed ID: 10720088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum leptin concentrations in pre- and postmenopausal women on sex hormone therapy.
    Bednarek-Tupikowska G; Filus A; Kuliczkowska-Płaksej J; Tupikowski K; Bohdanowicz-Pawlak A; Milewicz A
    Gynecol Endocrinol; 2006 Apr; 22(4):207-12. PubMed ID: 16723307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism.
    Mueck AO; Seeger H; Gräser T; Oettel M; Lippert TH
    Horm Metab Res; 2001 Dec; 33(12):744-7. PubMed ID: 11753761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
    Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study.
    Khosla S; Atkinson EJ; Melton LJ; Riggs BL
    J Clin Endocrinol Metab; 1997 May; 82(5):1522-7. PubMed ID: 9141544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial.
    Kalish GM; Barrett-Connor E; Laughlin GA; Gulanski BI;
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1646-52. PubMed ID: 12679451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial.
    Crandall C; Palla S; Reboussin B; Hu P; Barrett-Connor E; Reuben D; Greendale G
    J Womens Health (Larchmt); 2006; 15(1):14-23. PubMed ID: 16417414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal metabolism of estrogens.
    Adlercreutz H; Martin F; Pulkkinen M; Dencker H; Rimér U; Sjöberg NO; Tikkanen MJ
    J Clin Endocrinol Metab; 1976 Sep; 43(3):497-505. PubMed ID: 956337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women.
    Preston RA
    Climacteric; 2007 Feb; 10 Suppl 1():32-41. PubMed ID: 17364596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of aging and estradiol supplementation on GH axis dynamics in women.
    Lieman HJ; Adel TE; Forst C; von Hagen S; Santoro N
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3918-23. PubMed ID: 11502833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary estrogen metabolites and gastric cancer risk among postmenopausal women.
    Camargo MC; Song M; Xu X; Zhao I; Sampson JN; Etemadi A; Brenner H; Lee HW; Trabert B; Holleczek B; Schöttker B; Spaid K; Dawsey SM; Lee S; Shimura T; Park SK; Malekzadeh R; Kang D; Rabkin CS
    Cancer Rep (Hoboken); 2022 Jul; 5(7):e1574. PubMed ID: 34766475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is physical activity as effective in reducing risk of cardiovascular disease as estrogen replacement therapy in postmenopausal women?
    Wong S; Wong J
    Int J Nurs Stud; 1999 Oct; 36(5):405-14. PubMed ID: 10519685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.